Navigation Links
Palatin Technologies' Listing Compliance Plan Accepted by NYSE Alternext US
Date:3/5/2009

Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin Technologies' website at http://www.palatin.com.

Forward-looking Statements

Statements about future expectations of Palatin Technologies, Inc., including statements about performance related to the plan for regaining compliance with Exchange continued listing requirements, its development programs, proposed indications for its product candidates, pre-clinical activities, marketing collaborations, and all other statements in this document other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and as that term is defined in the Private Securities Litigation Reform Act of 1995. Palatin intends that such forward-looking statements be subject to the safe harbors created thereby. Palatin's actual results may differ materially from those discussed in the forward-looking statements for various reasons, including, but not limited to Palatin's ability to fund development of its technology, ability to establish and successfully complete clinical trials and pre-clinical studies and the results of those trials and studies, dependence on its partners for certain development activities, need for regulatory approvals and commercial acceptance of its products, ability to protect its intellectual property, and other factors discussed in the Palatin's periodic filings with the Securities and Exchange Commission. Palatin is not responsible for updating for events that occur after the date of this press release.


'/>"/>
SOURCE Palatin Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
2. Palatin Technologies Refutes Competitive Technologies Contention of Material Breach
3. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
4. Palatin Technologies to Report Fiscal Year 2008 First Quarter Results; Teleconference and Webcast on November 9, 2007
5. Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007
6. Palatin Technologies to Report Second Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on February 11th
7. Palatin Technologies, Inc. Reports Positive Results of a Phase I Clinical Study With PL-3994 for the Treatment of Congestive Heart Failure
8. Palatin Technologies to Report Third Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on May 13th
9. Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results
10. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
11. Palatin Technologies, Inc. Revised Call-In Number for Teleconference and Webcast to be held on September 30, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... MA (PRWEB) October 31, 2014 Following ... hosting a free learning webinar to introduce its new ... standards directors and biostatisticians. , Launched in September, Formedix ... company's suite of clinical trial automation tools. For the ... a web browser. And by introducing Formations – a ...
(Date:10/31/2014)... York, NY (PRWEB) October 31, 2014 ... such as healthcare, construction, finance and consumer electronics ... For this reason, industry research firm IBISWorld has ... industry to its growing industry report collection. , ... develop software for biometric technologies such as fingerprint, ...
(Date:10/30/2014)... , Oct. 30, 2014  Ardelyx, Inc. ... company focused on cardio-renal, gastrointestinal and metabolic diseases, ... 2014 financial results on Thursday, November 6, 2014. ... host a live conference call and webcast at ... and provide a business update. The ...
(Date:10/30/2014)... 30, 2014 Rancho BioSciences , ... have manually curated public data source TCGA ... the data is now available for other oncology ... public and internal data sources for their Pharma, Government ... of the data that becomes more easily accessible. ...
Breaking Biology Technology:Formedix to Introduce "Revolutionary" Clinical Trial Automation Software with Learning Webinar 2Biometrics Scan Software in the US Industry Market Research Report Now Available from IBISWorld 2Biometrics Scan Software in the US Industry Market Research Report Now Available from IBISWorld 3Ardelyx to Report Third Quarter 2014 Financial Results on November 6, 2014 2Rancho BioSciences Manually Curated TCGA Data Sets Available 2
... hiatus, Steven A. Schmidt has rejoined Renaissance Learning, ... April 26. , ,Schmidt, 51, left the Wisconsin Rapids-based ... He had served as executive vice president and senior ... succeed founder Terrance D. Paul as president. Paul, who ...
... term popularized by columnist Tom Friedman, requires (well) rounded ... and development of knowledge and skills. Organizations that want ... enriching workplace experiences if they wish to attract and ... you create an enriching workplace? It isn't easy and ...
... kept busy at the BIO Chicago industry show this week. ... laser-pointer pen or kangaroo lapel pin, he met with more ... mostly in prearranged sessions designed to help attendees make ... CEO of NeoClone , which manufactures monoclonal antibodies. It ...
Cached Biology Technology:Seven talent management practices that matter 2Seven talent management practices that matter 3Seven talent management practices that matter 4Seven talent management practices that matter 5Partner program is highlight of BIO for Wisconsin firm 2
(Date:10/30/2014)... 2014 – Bacteria in the gastrointestinal tract fulfill ... Yet, these same bacteria can induce strong inflammatory ... the gut and enter the bloodstream. , Although ... the body, chronic or systemic inflammation is linked ... established the involvement of inflammatory processes in the ...
(Date:10/29/2014)... who lose their hair as a consequence of chemotherapy ... improve the scalp cooling technology that prevents hair loss. ... being pioneered by global scalp cooling manufacturing company, Paxman ... biology department of the University of Huddersfield. , The ... who has a background in the pharmacology of cancer ...
(Date:10/29/2014)... on sunlight to make their food, but they also need ... scientists discovered a group of molecules in plants that shields ... Journal of the American Chemical Society , one team ... work. , Timothy Zwier and colleagues at Purdue University note ... can cause serious damage to plant DNA and, as a ...
Breaking Biology News(10 mins):Breakdown in gut barriers to bacteria may promote inflammation and craving in alcoholics 2New technology on the way to aid cancer suffers who lose their hair after chemotherapy 2
... for growing potatoes, at least for growing seed potatoes. ... project, together with Neiker-Tecnalia (the Basque Institute for Agricultural ... means of a novel system known as aeroponics. ... Spain, given that never before in this country the ...
... stressful lifestyle can take its toll, making us age faster and ... The same appears to be true of neurons in the ... in the journal Nature , dopamine-releasing neurons in a region ... requires lots of energy, creating stress that could lead to the ...
... movie theater swells; the roller coaster crests and begins ... you,re scared: your heart thumps, your stomach clenches, your ... fear doesn,t come from your heart, your stomach, your ... and it is therespecifically in an almond-shaped structure called ...
Cached Biology News:Newco produces seed potatoes in the open air 2Newco produces seed potatoes in the open air 3Stress takes its toll in Parkinson's disease 2Caltech scientists describe the delicate balance in the brain that controls fear 2Caltech scientists describe the delicate balance in the brain that controls fear 3Caltech scientists describe the delicate balance in the brain that controls fear 4
albumin from bovine serum (BSA), fluorescein conjugate...
DITHIOTHREITOL, 150UMOL, 1 EA. Dithiothreitol (DTT), 0.1 M Solution:, *0.1 M solution of DTT in high purity dH2O., *0.2 m filtered., *Storage: -20C. Category: SEQUENASE....
... Dithiothreitol, 1 g. High quality ... sample preparation that give consistent ... cells and tissues.Clean up samples ... volumes. Accurately quantitate protein for ...
ANTI 5-HYDROXYTRYPTOPHAN CONJ....
Biology Products: